Workflow
游戏运营
icon
Search documents
一则大消息,飙涨!
Zhong Guo Ji Jin Bao· 2025-08-05 10:59
Market Overview - The Hong Kong stock market showed strong performance on August 5, with the Hang Seng Index rising by 0.68% to close at 24,902.53 points, and the Hang Seng Tech Index increasing by 0.73% [2][3] - The total market turnover was 229.4 billion HKD, slightly lower than the previous trading day, with a net inflow of southbound funds amounting to 23.426 billion HKD [2] Biopharmaceutical Sector - The biopharmaceutical stocks gained significant attention, particularly Junshi Biosciences, which surged by 33.75% to 32.18 HKD per share, marking a year-to-date increase of 177.89% [4][7] - Guojin Securities reported a rising enthusiasm for global dual-antibody development, indicating a window for innovation in the domestic antibody industry, with Junshi Biosciences having extensive experience in monoclonal antibody development [7] Junshi Biosciences - Junshi Biosciences completed a placement of 41 million new shares on June 20, raising approximately 1.026 billion HKD, with 70% of the funds allocated for innovative drug research and 30% for general corporate purposes [8] - The company has developed a series of innovative dual-antibody molecules based on its experience in monoclonal antibodies, including the PD-1 monoclonal antibody, Toripalimab, which was one of the first domestically launched PD-1 inhibitors [7] Other Notable Stocks - Zhujiang Steel Pipe experienced a rise of 27.87% following an announcement regarding a proposed reduction of share premium to offset cumulative losses, which will result in a cumulative profit of approximately 92.224 million RMB by the end of 2024 [9][11] - Xindong Company, a gaming stock, saw a significant increase of 24.76% after announcing an expected revenue of at least 3.05 billion RMB for the first half of 2025, representing a growth of approximately 37% year-on-year [12][16]